129 related articles for article (PubMed ID: 27369102)
21. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
22. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.
Mansfield TA; Simon DB; Farfel Z; Bia M; Tucci JR; Lebel M; Gutkin M; Vialettes B; Christofilis MA; Kauppinen-Makelin R; Mayan H; Risch N; Lifton RP
Nat Genet; 1997 Jun; 16(2):202-5. PubMed ID: 9171836
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
Ferdaus MZ; McCormick JA
Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
[TBL] [Abstract][Full Text] [Related]
24. Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism.
Ostrosky-Frid M; Chávez-Canales M; Romo M; Grunfeld B; Simsolo R; Segura-Kato Y; Tusié-Luna T; Gamba G
Am J Hypertens; 2020 Mar; 33(3):278-281. PubMed ID: 31802109
[No Abstract] [Full Text] [Related]
25. Pseudohypoaldosteronism.
Riepe FG
Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
[TBL] [Abstract][Full Text] [Related]
26. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review.
Adachi M; Motegi S; Nagahara K; Ochi A; Toyoda J; Mizuno K
Endocr J; 2023 Jul; 70(7):723-729. PubMed ID: 37081692
[TBL] [Abstract][Full Text] [Related]
27. [Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): a case report].
Fortini A; Nenci G; Laureano R; Cappelletti C
G Ital Cardiol; 1996 Jan; 26(1):51-6. PubMed ID: 8682260
[TBL] [Abstract][Full Text] [Related]
28. [A Case of Pseudohypoaldosteronism Type Ⅱ (PHA2) Caused by a Novel Mutation of
Tang WW; Ma WX; Sun SY; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Sep; 52(5):890-894. PubMed ID: 34622611
[TBL] [Abstract][Full Text] [Related]
29. Pseudohypoaldosteronism type 2: CUL3 mutation confirmed 15 years following initial diagnosis.
Li B; Soule S; Wilkinson T; Florkowski C
Intern Med J; 2022 Apr; 52(4):691-692. PubMed ID: 35419964
[No Abstract] [Full Text] [Related]
30. Masked hypertension delaying diagnosis in Gordon's syndrome.
Pereira-Mestre R; Giannini O; Manzocchi V; Bianchetti MG
J Hypertens; 2012 Nov; 30(11):2240. PubMed ID: 23052049
[No Abstract] [Full Text] [Related]
31. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
Mayan H; Vered I; Mouallem M; Tzadok-Witkon M; Pauzner R; Farfel Z
J Clin Endocrinol Metab; 2002 Jul; 87(7):3248-54. PubMed ID: 12107233
[TBL] [Abstract][Full Text] [Related]
32. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene.
Gong H; Tang Z; Yang Y; Sun L; Zhang W; Wang W; Cui B; Ning G
Endocrine; 2008 Jun; 33(3):230-4. PubMed ID: 19016006
[TBL] [Abstract][Full Text] [Related]
33. Gordon's syndrome in pregnancy.
Morton A
Obstet Med; 2023 Sep; 16(3):151-155. PubMed ID: 37720005
[TBL] [Abstract][Full Text] [Related]
34. [Pseudo-hypoaldosteronisms].
Vantyghem MC; Perimenis P; Wemeau JL
Presse Med; 2004 Jan; 33(2):123-9. PubMed ID: 15026708
[TBL] [Abstract][Full Text] [Related]
35. Pseudohypoaldosteronism Type II Caused by
Wang Q; Cao BY; Su C; Li WJ; Gong CX
Chin Med J (Engl); 2018 Aug; 131(15):1879-1881. PubMed ID: 30058590
[No Abstract] [Full Text] [Related]
36. [Familial hyperkalemia syndrome (Gordon's syndrome)].
Baz M; Berland Y; Dussol B; Jaber K; Boobes Y
Presse Med; 1990 Dec; 19(43):1981-4. PubMed ID: 2149599
[TBL] [Abstract][Full Text] [Related]
37. A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidism.
Zhang R; Zhang S; Luo Y; Li M; Wen X; Cai X; Han X; Ji L
BMC Endocr Disord; 2021 May; 21(1):103. PubMed ID: 34022862
[TBL] [Abstract][Full Text] [Related]
38. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
[TBL] [Abstract][Full Text] [Related]
39. Hyperkalemia and hypertension: is this a "chloride-shunt" disorder?
Hirsch DJ
Clin Invest Med; 1990 Dec; 13(6):360-6. PubMed ID: 2078915
[No Abstract] [Full Text] [Related]
40. [Monogenic hypertension].
Bähr V; Oelkers W; Diederich S
Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
